A carregar...
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
INTRODUCTION: Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have tumors ≥ 4 cm. The survival advantage is modest with approximately 5% at 5 years. AREA...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863145/ https://ncbi.nlm.nih.gov/pubmed/29168933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2018.1409624 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|